ofloxacin and ornidazole

ofloxacin has been researched along with ornidazole in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Bari, SB; Chepurwar, SB; Fursule, RA; Shirkhedkar, AA; Surana, SJ1
Aboul-Enein, HY; Ali, AS; Elbashir, AA; Saad, B; See, KL1
Aboul-Enein, HY; Adnan, R; Al Azzam, KM; Saad, B1
Faruqui, AA; Joshi, C1
Verma, S1

Trials

1 trial(s) available for ofloxacin and ornidazole

ArticleYear
Evaluation of efficacy and tolerability of fixed dose combination of ofloxacin with ornidazole infusion (infusion O2) in the management of diarrhoea and dysentery.
    Journal of the Indian Medical Association, 2012, Volume: 110, Issue:3

    Topics: Adult; Amebicides; Anti-Bacterial Agents; Diarrhea; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Synergism; Dysentery; Female; Humans; Infusions, Parenteral; Male; Medication Therapy Management; Middle Aged; Ofloxacin; Ornidazole; Treatment Outcome

2012

Other Studies

6 other study(ies) available for ofloxacin and ornidazole

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Validated HPTLC method for simultaneous estimation of levofloxacin hemihydrate and ornidazole in pharmaceutical dosage form.
    Journal of chromatographic science, 2007, Volume: 45, Issue:8

    Topics: Amebicides; Anti-Bacterial Agents; Calibration; Chromatography, Thin Layer; Dosage Forms; Levofloxacin; Ofloxacin; Ornidazole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity

2007
Simultaneous determination of ofloxacin and ornidazole in pharmaceutical preparations by capillary zone electrophoresis.
    Biomedical chromatography : BMC, 2009, Volume: 23, Issue:12

    Topics: Anti-Bacterial Agents; Buffers; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Ofloxacin; Ornidazole; Pharmaceutical Preparations; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet

2009
Enantioselective analysis of ofloxacin and ornidazole in pharmaceutical formulations by capillary electrophoresis using single chiral selector and computational calculation of their inclusion complexes.
    Analytica chimica acta, 2010, Aug-03, Volume: 674, Issue:2

    Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Dosage Forms; Electrophoresis, Capillary; Limit of Detection; Linear Models; Models, Molecular; Ofloxacin; Ornidazole; Stereoisomerism

2010
Steroid modified tinea.
    BMJ (Clinical research ed.), 2017, 03-08, Volume: 356

    Topics: Administration, Cutaneous; Anti-Bacterial Agents; Antifungal Agents; Antitrichomonal Agents; Clobetasol; Disease Progression; Drug Combinations; Genital Diseases, Male; Glucocorticoids; Groin; Humans; Leg Dermatoses; Male; Naphthalenes; Ofloxacin; Ornidazole; Terbinafine; Thigh; Tinea; Young Adult

2017